FRANKFURT, Germany (December 7, 2022) – MarketVector IndexesTM (“MarketVector”) announced the licensing of the MVIS® Global Bionic Healthcare ESG Index (ticker: MVBION) to underlie the VanEck Bionic Engineering UCITS ETF.
The MVIS® Global Bionic Healthcare ESG Index (ticker: MVBION) includes companies that generate at least 50% of their revenue from medical, dental or vision-related implants, bio printing, prosthesis or preservation of organs and tissue.
“We have observed sound growth in the global bionics market which includes a range of niche healthcare solutions from medical implants to prostheses and bioprinting,” said Mirela Stefanova, Manager Equity Operations at MarketVector Indexes. These innovations in medical technology open new horizons to meet the rising needs of an aging population, significantly improve the quality of life for people with disabilities and pave the way for the discovery of potentially life-saving treatments. The MVIS® Global Bionic Healthcare ESG Index offers an investable benchmark to track the leading companies in this industry.”
The MVIS® Global Bionic Healthcare ESG Index (ticker: MVBION) is weighted by free float market capitalization and reviewed on a quarterly basis. The index is calculated in USD as a price index and a total return net index. Capping factors are applied to avoid overweighting of single index components.
“The proportion of the elderly population is rising and with it the demand for technical solutions such as hearing and visual aids, pacemakers, artificial joints and the like that improve the quality of life in the old age,” says Martijn Rozemuller, CEO at VanEck Europe. “At the same time, increasingly available bionic tools are helping people with chronic diseases such as diabetes or functional disorders.”
Detailed information about the index, including methodology details and index data, is available on the MarketVector Indexes website.